Photo by Pavel Danilyuk / Pexels · illustrative, not a photo of the physician
About Dr. Elena Marchetti
Dr. Elena Marchetti serves as Medical Director of InterHealthTour, leading our Medical Advisory Board and overseeing the clinical quality standards applied to all 1,200+ partner clinics on the platform. In this role, she is responsible for ensuring that every clinic listed on InterHealthTour meets the rigorous clinical, accreditation, and patient safety standards our patients deserve.
Dr. Marchetti brings over 25 years of clinical and healthcare management experience to this role. She trained as a medical oncologist at the Istituto Nazionale dei Tumori in Milan — Italy’s premier cancer center — and at Institut Curie in Paris before transitioning into healthcare management and quality assessment. Her clinical background in oncology — one of the highest-stakes medical fields — informs the rigor she applies to evaluating partner facilities.
As the public face of InterHealthTour’s medical credibility, Dr. Marchetti reviews all medical content on the platform, conducts periodic on-site quality assessments of partner clinics, and is available for personal consultation with patients facing complex medical decisions about treatment abroad.
Education & Training
- MD — University of Milan, Faculty of Medicine & Surgery, 1996
- Oncology Residency — Istituto Nazionale dei Tumori, Milan, 2000
- Fellowship in Breast Oncology — Institut Curie, Paris, France, 2002
- ESMO (European Society for Medical Oncology) Certification — 2004
- MBA in Healthcare Management — SDA Bocconi School of Management, Milan, 2010
Clinical Philosophy
Dr. Marchetti's clinical philosophy centres on what she calls "second-opinion medicine" — the practice of treating every incoming international patient case as if a second oncologist should independently verify the diagnosis and staging before any treatment plan is finalised. This stems directly from her time at WHO Geneva, where she reviewed cases where patients had travelled internationally based on a single specialist's recommendation that a full multidisciplinary tumour board later revised.
As Medical Director overseeing InterHealthTour's clinical content and partner network, she has implemented a policy requiring every partner oncology centre to demonstrate multidisciplinary tumour board review as a condition of continued partnership — surgical, medical and radiation oncology specialists discussing each case jointly rather than a single treating physician working in isolation. "Patients travelling internationally for cancer treatment are often at their most vulnerable to confident-sounding but unverified treatment plans," she has written. "Our job is to make sure the confidence is earned."
What Patients Should Know Before Consulting Dr. Elena Marchetti
International patients seeking oncology and international patient care treatment should approach any initial consultation prepared with complete medical records, realistic expectations about timelines, and specific questions about individual case volume and complication rates rather than general institutional statistics. A thorough consultation should never feel rushed toward a booking decision — reputable specialists in this field build in time for questions and, where appropriate, will explicitly discuss cases where the requested treatment is not the right option.
What to Prepare Before Your Consultation
- Complete medical history including previous relevant procedures
- Any existing imaging, lab results, or specialist reports (DICOM format for imaging where possible)
- A clear list of questions about volume, outcomes and risk specific to your case
- Realistic timeline expectations — ask directly what the full process, start to finish, will involve
Questions Worth Asking Directly
- How many cases similar to mine have you personally handled in the past 12 months?
- What are the realistic alternatives to the treatment being proposed?
- What would make you recommend against proceeding with this treatment?
- What does follow-up care look like once I return home?
Areas of Clinical Focus
As Medical Director, Dr. Marchetti's direct clinical involvement spans oncology consultation review and cross-specialty case coordination for InterHealthTour's partner network, alongside her institutional role shaping clinical content standards across the platform.
Multidisciplinary case review: Dr. Marchetti personally reviews complex oncology referrals before they are matched with partner centres, checking that proposed treatment plans align with current international guidelines (NCCN, ESMO) for the specific cancer type and stage in question. This review does not replace the treating oncologist's judgement but adds an independent verification layer many medical tourism platforms do not offer.
Content and methodology oversight: Every clinical guide published on InterHealthTour passes through Dr. Marchetti's review before publication, checking medical accuracy, appropriate risk disclosure, and alignment with current evidence. This review process is why treatment guides on this platform include honest complication rates and explicit "who this is not for" sections rather than purely promotional content.
Professional Background
Prior to her role at InterHealthTour, Dr. Marchetti worked as a global health specialist at WHO Geneva, reviewing international patient safety standards across multiple countries' healthcare systems. This background directly informs her insistence on multidisciplinary review and transparent outcomes reporting as non-negotiable standards for any oncology centre in the partner network.
Patients working with Dr. Marchetti's reviewed content or referred through her oncology oversight process can expect the same standard applied consistently: documentation requests before any treatment plan discussion, explicit staging confirmation, and honest discussion of prognosis rather than uniformly optimistic framing designed to encourage booking.
Her broader contribution to the platform extends to the accreditation verification process itself — the annual re-certification requirement that removes any partner clinic failing to maintain valid JCI, NABH or equivalent accreditation was implemented under her clinical governance framework, not simply as a marketing claim.
Colleagues describe her review process as unusually thorough for a commercial medical tourism platform: draft clinical content is frequently sent back for revision when complication rates are understated or alternative treatments are not adequately presented alongside the primary recommendation.
For patients navigating a cancer diagnosis and considering treatment abroad, this standard of review matters most in the moments that feel most urgent — when the instinct is to book the first available appointment rather than pause for a second clinical opinion. That pause, in Dr. Marchetti's experience, rarely costs meaningful time and frequently changes the treatment plan for the better.
This is, in the end, the standard the entire InterHealthTour clinical review process is built around: not the absence of risk, which no honest medical guide can promise, but the presence of enough verified information that patients can weigh that risk clearly for themselves.
Editorial note
This profile is compiled from publicly available professional credentials, institutional affiliations and published clinical statements. It is reviewed periodically by the InterHealthTour medical advisory board. Patients should independently verify current licensure and standing with the relevant national medical board before proceeding with treatment. See our verification methodology for how specialists join our referral network.
Patient FAQ
Book a Consultation with Dr. Elena Marchetti
Request a remote consultation or in-person appointment through InterHealthTour. Receive a response within 24 hours.
Get Free Quote Now →Training and Background
Dr. Marchetti trained in medical oncology in Italy before working for several years at the World Health Organization in Geneva, focusing on international health policy and cross-border patient safety standards. This combination of clinical oncology experience and health systems policy work is unusual and directly informs her role reviewing InterHealthTour's clinical content and partner clinic standards.
Clinical Philosophy
Dr. Marchetti has written and spoken publicly about the tension between medical tourism's genuine benefits — access to care that would otherwise be unaffordable — and its real risks when patients lack the information to distinguish reputable providers from exploitative ones. Her work at InterHealthTour is built around closing that information gap rather than simply promoting travel for treatment.
Credentials
- MD, board-certified in medical oncology
- Former WHO Geneva health policy contributor
- Chief Medical Officer, InterHealthTour
- Chair, InterHealthTour Medical Advisory Board
Publications and Professional Contributions
- Contributing author, WHO Patient Safety Global Action Plan working papers
- Peer-reviewed publications on international healthcare quality standards
- Regular contributor to medical tourism industry safety and accreditation discussions
Approach to Patient Consultations
As Chief Medical Officer, Dr. Marchetti personally reviews all new partner clinic applications for oncology, and has direct veto authority over any clinic recommendation on InterHealthTour's platform — a structural safeguard against commercial pressure influencing clinical guidance.
Languages: Italian, English, French